Search Results - "Toublanc, Nathalie"
-
1
Development of an Integrated Population Pharmacokinetic Model for Oral Levetiracetam in Populations of Various Ages and Ethnicities
Published in Drug metabolism and pharmacokinetics (2014)“…Levetiracetam [E Keppra®] is a second generation antiepileptic drug for different types of epilepsy in adults and children ≥1 month. The objective is to…”
Get full text
Journal Article -
2
Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study
Published in Epilepsia (Copenhagen) (01-07-2006)“…Purpose: The primary objective of this placebo‐controlled study was to evaluate the safety and tolerability of levetiracetam (LEV) administered intravenously…”
Get full text
Journal Article -
3
Development of an Integrated Population Pharmacokinetic Model for Oral Levetiracetam in Populations of Various Ages and Ethnicities
Published in DRUG METABOLISM AND PHARMACOKINETICS (25-02-2014)“…[Summary] Levetiracetam [E Keppra(R)(R)] is a second generation antiepileptic drug for different types of epilepsy in adults and children >1 month. The…”
Get full text
Journal Article -
4
Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study
Published in Annals of the rheumatic diseases (01-11-2017)“…Women with chronic inflammatory diseases face uncertainty regarding the safety of biologics during breast feeding. CRADLE was the first industry-sponsored…”
Get more information
Journal Article -
5
Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment
Published in Clinical drug investigation (01-11-2014)“…Background and Objective The anti-epileptic drug levetiracetam is excreted renally. The objective of this trial was to evaluate the pharmacokinetics of…”
Get full text
Journal Article -
6
Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and Adolescents with Epilepsy: Dosing Recommendations
Published in Clinical pharmacokinetics (01-01-2008)“…Objective: To characterize levetiracetam pharmacokinetics, identify significant covariate relationships and identify doses in children that achieve blood…”
Get full text
Journal Article -
7
Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects
Published in Clinical drug investigation (01-08-2015)“…Background and Objective Levetiracetam is available in China as adjunctive oral therapy for partial-onset seizures. This study was conducted to evaluate the…”
Get full text
Journal Article -
8
-
9
-
10
Prospective Open-Label, Single-Arm, Multicenter, Safety, Tolerability, and Pharmacokinetic Studies of Intravenous Levetiracetam in Children With Epilepsy
Published in Journal of child neurology (01-11-2013)“…Levetiracetam given via intravenous administration has been shown to be an effective alternative in adults with epilepsy when oral administration is not…”
Get full text
Journal Article -
11
Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects
Published in Clinical therapeutics (01-05-2006)“…Background: Antiepileptic drugs are usually administere dorally, but alternative routes of drug delivery may be required when oral administration is not…”
Get full text
Journal Article -
12
Seletracetam (UCB 44212)
Published in Neurotherapeutics (2007)“…Better pharmacotherapies for epilepsy are needed for patients who are refractory to or have tolerability difficulties with current treatments. Seletracetam, a…”
Get full text
Journal Article -
13
Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration
Published in European journal of drug metabolism and pharmacokinetics (01-12-2015)“…The intravenous (iv) formulation of levetiracetam has been available in clinical practice worldwide for several years, but not in Japan. Two open-label studies…”
Get full text
Journal Article -
14
Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements
Published in Clinical pharmacology and therapeutics (01-12-1998)“…Objectives To develop a model for 24‐hour ambulatory blood pressure measurements (ABPM) that can be applied in a pharmacokinetic‐pharmacodynamic model. Methods…”
Get full text
Journal Article -
15